179 related articles for article (PubMed ID: 38440179)
1. The safety and efficacy of Houtou Jianweiling tablet in patients with chronic non-atrophic gastritis: a double-blind, non-inferiority, randomized controlled trial.
Shah MR; Fatima S; Khan SN; Shafiullah ; Azam Z; Shaikh H; Majid S; Chengdong H; Daijun Z; Wang W
Front Pharmacol; 2024; 15():1293272. PubMed ID: 38440179
[No Abstract] [Full Text] [Related]
2. A randomized, double-blind, positive-controlled, Phase-II clinical trial to evaluate efficacy and safety of Fuke Qianjin capsule in Pakistani patients with pelvic inflammatory disease.
Shah MR; Khan SN; Fatima S; Yao L; Yuan H; Ullah S; Ainuddin J; Zeng C; Zheng Y; Sahar N; Anwar S; Zhu M; Ma C; Kumari K; Wang W; Liu R
Front Pharmacol; 2024; 15():1287321. PubMed ID: 38584600
[No Abstract] [Full Text] [Related]
3. Efficacy and safety of Chinese herbal medicine Qirui Weishu capsule in treating chronic non-atrophic gastritis: A multicentre, double-blind, randomized controlled clinical trial.
Chen HF; Gong Y; Huang Z; Zhao G; Chen ZM; Zen YM; Li HZ; Hu YL
J Ethnopharmacol; 2022 Aug; 294():115341. PubMed ID: 35551978
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Chinese herbal compound prescriptions combined with Chinese medicine powder based on traditional Chinese medicine syndrome differentiation for treatment of chronic atrophic gastritis with erosion: a multi-center, randomized, positive-controlled clinical trial.
Zhang T; Zhang B; Xu J; Ren S; Huang S; Shi Z; Guo S; Bian L; Wang P; Wang F; Cai Y; Tang X
Chin Med; 2022 Dec; 17(1):142. PubMed ID: 36550503
[TBL] [Abstract][Full Text] [Related]
6. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
8. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
[TBL] [Abstract][Full Text] [Related]
9. The efficacy and safety of Jian-Wei-Qu-Tong Pills for the treatment of chronic non-atrophic gastritis (spleen and stomach qi deficiency with damp-heat stasis syndrome): study protocol for a phase II, randomized controlled trial.
Zhang XX; Chen WW; She B; Luo RJ; Shi N; Xue P; Yang XN; Xia Q
Trials; 2014 Jul; 15():272. PubMed ID: 25002101
[TBL] [Abstract][Full Text] [Related]
10. Jinhua Qinggan granules for non-hospitalized COVID-19 patients: A double-blind, placebo-controlled, and randomized controlled trial.
Shah MR; Fatima S; Khan SN; Ullah S; Himani G; Wan K; Lin T; Lau JYN; Liu Q; Lam DSC
Front Med (Lausanne); 2022; 9():928468. PubMed ID: 35979216
[TBL] [Abstract][Full Text] [Related]
11. Interferon Inhibition for Lupus with Anifrolumab: Critical Appraisal of the Evidence Leading to FDA Approval.
Loncharich MF; Anderson CW
ACR Open Rheumatol; 2022 Jun; 4(6):486-491. PubMed ID: 35157371
[TBL] [Abstract][Full Text] [Related]
12. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
14. [Xifeng zhidong tablet and the placebo control treatment of tic disorder children patients of internal disturbance of Gan-wind with phlegm syndrome: a clinical study].
Ma R; Hu SY; Tian T; Wei XW; Xiang XX; Ding Y; Wang XF; Chen YY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Apr; 34(4):426-30. PubMed ID: 24812897
[TBL] [Abstract][Full Text] [Related]
15. A Phase II Pilot Trial to Evaluate
Noudjiegbe AN; Alikekere FN; Tchehouenou H; Langa Y; Ota DS; Degbelo JE; Allabi ACE
Evid Based Complement Alternat Med; 2020; 2020():8715021. PubMed ID: 32215047
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Traditional Chinese Medicine, Maxingshigan-Weijing in the management of COVID-19 patients with severe acute respiratory syndrome: A structured summary of a study protocol for a randomized controlled trial.
Zeng C; Yuan Z; Pan X; Zhang J; Zhu J; Zhou F; Shan Z; Yuan Y; Ye R; Cheng J
Trials; 2020 Dec; 21(1):1029. PubMed ID: 33357239
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of Elian Granules in treating chronic atrophic gastritis: study protocol for a randomized, double-blind, placebo-controlled, multicenter clinical trial.
Gu Z; Jia Q; Cong J; Cen R; Chen Y; Wu C; Gong B; Tang X; Ling J
Trials; 2022 May; 23(1):437. PubMed ID: 35610625
[TBL] [Abstract][Full Text] [Related]
18. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
19. Exploration of the utility of different doses of Qingfei Dayuan granules: a multicenter, randomized, double-blind, placebo-controlled trial.
Zhu X; Li W; Yang Y; Li H; Yang M; Zhang J; Li X; Yan G; Wu X; Zhao W; Cui M; Yang X; Hu X; Huang J; Ba Y
Aging (Albany NY); 2024 Feb; 16(5):4503-4517. PubMed ID: 38412322
[TBL] [Abstract][Full Text] [Related]
20. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Feagan BG; Macdonald JK
Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
